Pain management in hidradenitis suppurativa and a proposed treatment algorithm

J Am Acad Dermatol. 2021 Jul;85(1):187-199. doi: 10.1016/j.jaad.2020.09.039. Epub 2020 Sep 17.

Abstract

Pain contributes substantially to reduced quality of life in individuals living with hidradenitis suppurativa (HS). Although improved understanding of HS pathogenesis and treatment has resulted in improved evidence-based HS management guidelines, comprehensive pain management guidelines have yet to be developed. Few HS-specific data exist to guide pharmacologic analgesia; however, recognizing HS pain as either acute or chronic and predominantly nociceptive (aching and gnawing pain due to tissue damage) versus neuropathic (burning-type pain due to somatosensory nervous system dysfunction) provides a conceptual framework for applying outside pain management practices to HS management. This article incorporates the best available evidence from the HS and pain literature to propose an HS pain algorithm that integrates psychological, pharmacologic, and complementary and alternative treatment modalities.

Keywords: acute pain; chronic pain; hidradenitis suppurativa; neuropathic; nociceptive; pain management; treatment.

Publication types

  • Review

MeSH terms

  • Algorithms*
  • Analgesics / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Chronic Pain / etiology
  • Chronic Pain / psychology
  • Chronic Pain / therapy
  • Cognitive Behavioral Therapy
  • Complementary Therapies
  • Depression / etiology
  • Depression / therapy
  • Hidradenitis Suppurativa / complications*
  • Humans
  • Neuralgia / etiology
  • Neuralgia / psychology
  • Neuralgia / therapy*
  • Neurotransmitter Agents / therapeutic use
  • Nociceptive Pain / etiology
  • Nociceptive Pain / psychology
  • Nociceptive Pain / therapy*
  • Pain Management / methods*
  • Practice Guidelines as Topic

Substances

  • Analgesics
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antidepressive Agents, Tricyclic
  • Neurotransmitter Agents